ARCHIVES

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006